Liang XJ - Search Results

1

Single-walled carbon nanotubes alter cytochrome c electron transfer and modulate mitochondrial function.

Ma X, Zhang LH, Wang LR, Xue X, Sun JH, Wu Y, Zou G, Wu X, Wang PC, Wamer WG, Yin JJ, Zheng K, Liang XJ. Ma X, et al. Among authors: liang xj. ACS Nano. 2012 Dec 21;6(12):10486-96. doi: 10.1021/nn302457v. Epub 2012 Nov 29. ACS Nano. 2012. PMID: 23171082 Free PMC article.

2

Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells.

Liang XJ, Yin JJ, Zhou JW, Wang PC, Taylor B, Cardarelli C, Kozar M, Forte R, Aszalos A, Gottesman MM. Liang XJ, et al. Exp Cell Res. 2004 Feb 15;293(2):283-91. doi: 10.1016/j.yexcr.2003.10.012. Exp Cell Res. 2004. PMID: 14729466

3

Different roles for K+ channels in cisplatin-resistant cell lines argue against a critical role for these channels in cisplatin resistance.

Liang XJ, Taylor B, Cardarelli C, Yin JJ, Annereau JP, Garfield S, Wincovitch S, Szakács G, Gottesman MM, Aszalos A. Liang XJ, et al. Anticancer Res. 2005 Nov-Dec;25(6B):4113-22. Anticancer Res. 2005. PMID: 16309205 Free article.

4

Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines.

Liang XJ, Yin JJ, Taylor B, Winkovitch SM, Garfield SH, Shen DW, Gottesman MM, Aszalos A. Liang XJ, et al. Cancer Chemother Pharmacol. 2008 Nov;62(6):977-84. doi: 10.1007/s00280-008-0687-9. Epub 2008 Feb 15. Cancer Chemother Pharmacol. 2008. PMID: 18274748

5

Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.

Yin JJ, Lao F, Meng J, Fu PP, Zhao Y, Xing G, Gao X, Sun B, Wang PC, Chen C, Liang XJ. Yin JJ, et al. Among authors: liang xj. Mol Pharmacol. 2008 Oct;74(4):1132-40. doi: 10.1124/mol.108.048348. Epub 2008 Jul 17. Mol Pharmacol. 2008. PMID: 18635669

6

SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism.

Liang XJ, Finkel T, Shen DW, Yin JJ, Aszalos A, Gottesman MM. Liang XJ, et al. Mol Cancer Res. 2008 Sep;6(9):1499-506. doi: 10.1158/1541-7786.MCR-07-2130. Epub 2008 Aug 22. Mol Cancer Res. 2008. PMID: 18723829 Free PMC article.

7

Biopharmaceutics and therapeutic potential of engineered nanomaterials.

Liang XJ, Chen C, Zhao Y, Jia L, Wang PC. Liang XJ, et al. Curr Drug Metab. 2008 Oct;9(8):697-709. doi: 10.2174/138920008786049230. Curr Drug Metab. 2008. PMID: 18855608 Free PMC article. Review.

8

The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials.

Yin JJ, Lao F, Fu PP, Wamer WG, Zhao Y, Wang PC, Qiu Y, Sun B, Xing G, Dong J, Liang XJ, Chen C. Yin JJ, et al. Among authors: liang xj. Biomaterials. 2009 Feb;30(4):611-21. doi: 10.1016/j.biomaterials.2008.09.061. Epub 2008 Nov 4. Biomaterials. 2009. PMID: 18986699 Free PMC article.

9

Building scientific progress without borders: nanobiology and nanomedicine in China and the U.S.

Wang PC, Blumenthal RP, Zhao Y, Schneider JA, Miller N, Grodzinski P, Gottesman MM, Tinkle S, Wang K, Wang C, Liang XJ. Wang PC, et al. Among authors: liang xj. Cancer Res. 2009 Jul 1;69(13):5294-5. doi: 10.1158/0008-5472.CAN-09-0563. Epub 2009 Jun 23. Cancer Res. 2009. PMID: 19549890 Free PMC article. No abstract available.

10

Circumventing tumor resistance to chemotherapy by nanotechnology.

Liang XJ, Chen C, Zhao Y, Wang PC. Liang XJ, et al. Methods Mol Biol. 2010;596:467-88. doi: 10.1007/978-1-60761-416-6_21. Methods Mol Biol. 2010. PMID: 19949937 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

505 results

Search Page

Filters